ReadYourDNA

rs7498665 (SH2B1)

What you carry at this position in your DNA and what research says about it.

Obesity and Weight Risk: 8/10 evidence, 36 publications.

You're viewing every possible genotype for this variant.

None of these is your result. Use the genotype toggle to compare them, then sign up and upload your DNA to see which one is yours.

Sample genotype (not yours): A/A

Typical Obesity and Weight Risk

This genotype is associated with standard appetite regulation and a typical body mass index. Baseline metabolic health is generally easier to maintain.

What this genotype means: Standard appetite regulation; Typical body fat distribution.

Sample genotype (not yours): A/G

Slightly Increased Obesity Risk

Carrying one copy of the variant is linked to a slightly higher average body mass index.

What this genotype means: Slightly higher baseline appetite; Increased tendency to store abdominal fat.

Sample genotype (not yours): G/G

Higher Obesity and Weight Risk

Carrying two copies of the variant is linked to a higher average body mass index and increased abdominal fat.

What this genotype means: Higher risk of elevated body mass index; Greater accumulation of visceral fat; Slightly elevated liver enzymes under metabolic stress.

About SH2B1

Gene function and biological role

Gene Function: The SH2B1 gene encodes an essential adaptor protein that plays a critical role in cellular signaling pathways [1]. It acts as a key regulator of both leptin and insulin signaling, which are crucial for maintaining energy balance and glucose homeostasis [1]. In the brain, particularly within the hypothalamus, this protein enhances leptin receptor signaling to help control appetite and body weight [1]. In peripheral tissues, it facilitates insulin signaling to promote proper glucose uptake and prevent insulin resistance [2]. Animal studies show that a complete lack of this gene leads to severe overeating, morbid obesity, and type 2 diabetes [1].

Variant Impact: The rs7498665 variant is a missense mutation in the SH2B1 gene that alters the amino acid at position 484 from threonine to alanine [1]. A substitution of this nature occurs in a highly conserved region of the protein, potentially altering its interaction with signaling partners [2]. Although the single amino acid substitution is not enough to cause severe monogenic obesity on its own, it significantly influences common, complex weight gain [3]. Large-scale genetic studies have consistently linked this alteration to subtle shifts in body mass index, body fat distribution, and metabolic health [4].

Key Insight: This variant affects how your brain processes leptin, the hormone responsible for signaling fullness, which can subtly influence daily appetite and snacking behavior.

Location: SH2B1. Chromosome 16 · 16p11.2 · 28.9 Mb

Genotype Frequencies

Estimated prevalence by population

Global 43.4%; European 36.6%; African 53.3%; East Asian 76.7%; South Asian 59.7%; Americas 34.9%; Ashkenazi 53.3%; Finnish 32.2%; Middle Eastern 59.7%; Amish 57.5%.

Estimated AA genotype frequency.

Global 44.0%; European 47.8%; African 39.4%; East Asian 21.8%; South Asian 35.1%; Americas 48.3%; Ashkenazi 39.4%; Finnish 49.1%; Middle Eastern 35.2%; Amish 36.6%.

Estimated AG genotype frequency.

Global 12.5%; European 15.6%; African 7.3%; East Asian 1.5%; South Asian 5.2%; Americas 16.7%; Ashkenazi 7.3%; Finnish 18.7%; Middle Eastern 5.2%; Amish 5.8%.

Estimated GG genotype frequency.

Associated Traits

Showing effects for A/A genotype

Cardiovascular & Metabolic

Obesity & Body Composition

Obesity. Evidence: 8/10. Source: PMID 19079260. Typical Risk.

Waist Circumference. Evidence: 10/10. Source: PMID 25673412. Typical.

Visceral Fat. Evidence: 8/10. Source: PMID 31501611. Typical.

Organ Systems

Liver Function & Disease

Liver Enzyme Levels. Evidence: 7/10. Source: PMID 38632349. Typical ALT.

Showing effects for A/G genotype

Obesity. Evidence: 8/10. Source: PMID 19079260. Increased Risk.

Waist Circumference. Evidence: 10/10. Source: PMID 25673412. Slightly Higher.

Visceral Fat. Evidence: 8/10. Source: PMID 31501611. Slightly Increased.

Liver Enzyme Levels. Evidence: 7/10. Source: PMID 38632349. Slightly Elevated ALT.

Showing effects for G/G genotype

Obesity. Evidence: 8/10. Source: PMID 19079260. Higher Risk.

Waist Circumference. Evidence: 10/10. Source: PMID 25673412. Higher.

Visceral Fat. Evidence: 8/10. Source: PMID 31501611. Increased.

Liver Enzyme Levels. Evidence: 7/10. Source: PMID 38632349. Elevated ALT.

What AA Genotype Means

What this genotype means for the people who carry it

Sample genotype: AA (Homozygous)

Maintaining a typical body mass index and a standard risk of weight-related metabolic issues is highly associated with this genotype [1]. Cellular signaling pathways for leptin and insulin function at baseline levels, supporting normal appetite regulation and energy balance [2]. Large-scale population studies show that people with these genetic markers tend to have lower waist circumferences and less visceral fat compared to those carrying the variant allele [3]. Physical activity and balanced nutrition work efficiently to maintain metabolic health without an added genetic hurdle [4]. Additionally, standard insulin sensitivity helps protect cardiovascular health and maintains normal liver enzyme levels [5].

Standard appetite regulation; Typical body fat distribution.

What AG Genotype Means

Sample genotype: AG (Heterozygous)

An elevated likelihood of experiencing a higher body mass index is associated with this single-copy variant [1]. Leptin signaling in the brain may be slightly less efficient, which can subtly influence appetite and food intake [2]. Research indicates a higher likelihood of accumulating fat around the waist and within visceral organs [3]. Although this genetic nudge raises the baseline risk for obesity, lifestyle factors play a massive role in determining actual outcomes [4]. Higher glucose levels can compound the genetic risk for weight gain [5].

Slightly higher baseline appetite; Increased tendency to store abdominal fat.

What GG Genotype Means

Sample genotype: GG (Homozygous)

The presence of two alanine alleles is associated with the highest genetic risk for elevated body mass index and obesity at this locus [1]. Reduced efficiency in leptin and insulin signaling pathways often results from this double amino acid substitution [2]. This reduction often manifests as increased appetite, higher body fat percentage, and a greater accumulation of visceral fat around internal organs [3]. Clinical studies show that these genetic factors also correlate with higher levels of liver enzymes like alanine aminotransferase, indicating potential metabolic stress [4].

Higher risk of elevated body mass index; Greater accumulation of visceral fat; Slightly elevated liver enzymes under metabolic stress.

Related Variants

Variants with shared genetic architecture

rs7359397 · SH2B1 Gene · Chr 16 · Metabolic and Weight Risk

rs4788102 · SH2B1 Gene · Chr 16 · Weight and Obesity Risk

rs3817334 · MTCH2 Gene · Chr 11 · Obesity and BMI Risk

Sources

The SH2B gene is associated with serum leptin and body fat in normal female twins.

The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells.

Mutation screen in the GWAS derived obesity gene SH2B1 including functional analyses of detected variants.

Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity.

Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.

Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study.

Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis.

Analyses of non-synonymous obesity risk alleles in SH2B1 (rs7498665) and APOB48R (rs180743) in obese children and adolescents undergoing a 1-year lifestyle intervention.

Back to Variant Explorer

Content updated August 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com